1 / 16

Reclast Infusion Center Analysis August 4, 2008

Reclast Infusion Center Analysis August 4, 2008. Key Findings. 93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district. 45.1K targets have infusion access within 10 miles

kimball
Download Presentation

Reclast Infusion Center Analysis August 4, 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ReclastInfusion Center AnalysisAugust 4, 2008

  2. Key Findings • 93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district. • 45.1K targets have infusion access within 10 miles • 3.3K targets do not have infusion access within 10 miles • There is a positive relationship between Reclast sales and the number of infusion centers • As the number of infusion centers increases, Reclast sales increase

  3. Infusion Center Access in Geigy Regions

  4. Geigy Region: Atlanta • 5,821 targets have infusion access within 10 miles (black dots) • 428 targets do not have infusion access within 10 miles (red triangles)

  5. Geigy Region: Boston • 4.606 targets have infusion access within 10 miles (black dots) • 218 targets do not have infusion access within 10 miles (red triangles)

  6. Geigy Region: Chicago • 7,426 targets have infusion access within 10 miles (black dots) • 550 targets do not have infusion access within 10 miles (red triangles)

  7. Geigy Region: Cincinnati • 6,339 targets have infusion access within 10 miles (black dots) • 350 targets do not have infusion access within 10 miles (red triangles)

  8. Geigy Region: Dallas • 5,661 targets have infusion access within 10 miles (black dots) • 573 targets do not have infusion access within 10 miles (red triangles)

  9. Geigy Region: Morristown • 4,828 targets have infusion access within 10 miles (black dots) • 278 targets do not have infusion access within 10 miles (red triangles)

  10. Geigy Region: Raleigh • 5,141 targets have infusion access within 10 miles (black dots) • 512 targets do not have infusion access within 10 miles (red triangles)

  11. Geigy Region: San Ramon • 5,109 targets have infusion access within 10 miles (black dots) • 307 targets do not have infusion access within 10 miles (red triangles)

  12. Relationship between Reclast Sales and Infusion Access Using Bone-Uro District Data

  13. Bone/Uro Districts: Correlation between Reclast sales and Reclast Ready sites is 0.60 • There is a positive association between Reclast sales and Reclast Ready sites Data ending June 2008

  14. Bone/Uro Districts: Correlation between Reclast sales and estimated 65+ women patients per Reclast Ready facility is -0.76 • There is a positive association between sales and Reclast Ready sites Estimated 65+ Women Patients = 55% of 65+ Women Data ending June 2008

  15. Bone-Uro Districts: Correlation between estimated 65+ women patients and oral BP TRxs is 0.90 but correlation between 65+ Women patients and Reclast sales is only 0.42 Estimated 65+ Women Patients = 55% of 65+ Women Data ending June 2008

  16. Back-UpInfusion Center Access in Bone-Uro Districts

More Related